By Sabela Ojea


Shares of Danaher Corp. on Tuesday rose about 4% after the medical company said it expects fourth-quarter sales to rise in the low-single-digit percent range.

At 13:27 E.T., shares were up 4.2%, at $265.64.

The designer and manufacturer of medical industrial and commercial products and services said it delivered better-than-expected fourth-quarter results.

"We are very pleased with the continued strength in our base business which had another quarter of high-single digit core revenue growth," Chief Executive Rainer Blair said.

Additionally, the company said that its Cepheid molecular diagnostic business performed ahead of views after securing more than $1 billion in respiratory testing revenue in the fourth quarter.


Write to Sabela Ojea at sabela.ojea@wsj.com


(END) Dow Jones Newswires

01-10-23 1359ET